Just days after scoring a big win from the FDA, a D.C. pharmaceutical company has learned that its years-long quest to market another drug for jet lag has been rejected, delivering a blow to its stock ...

These 4 big technology bets will reshape the global economy in 2026 ...

Editing and Publishing Made Easy During editing, VideoProc Vlogger offers a lightweight non-linear environment for fast assembly. With pre-enhanced footage, creators avoid running heavy AI effects ...

Investing.com -- Vanda Pharmaceuticals (NASDAQ:VNDA) stock fell 12% Thursday morning after the company announced that the U.S. Food and Drug Administration (FDA) rejected its application for HETLIOZ ...

Shares of Vanda Pharmaceuticals Inc. (VNDA) fell 10% in premarket trading on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) stated that its supplemental New Drug ...

WASHINGTON, Jan. 8, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received a decision letter from the U.S. Food and Drug Administration's (FDA) ...

WASHINGTON, Jan. 8, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced that it has received a decision letter from the U.S. Food and Drug Administration's (FDA) Center for Drug ...

WASHINGTON - The U.S. Food and Drug Administration has rejected Vanda Pharmaceuticals Inc.’s (NASDAQ:VNDA) supplemental New Drug Application for HETLIOZ (tasimelteon) as a treatment for jet lag ...

Artificial intelligence or AI is no longer a future concept—it's already shaping how we work, learn and live.

Applications open Tuesday, January 13, for Tennessee’s school voucher program, called the Education Freedom Scholarship.

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...